Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Vrimolol H 50/12.5 Tablet ER

Prescription Icon
Prescription Required

Marketer

Vridam Healthcare Pvt Ltd

Salt Composition

Metoprolol Succinate (47.50mg) + Hydrochlorothiazide (12.5mg)

Overview Vrimolol H 50/12.5 Tablet ER

Cardiolol XT 50/12.5 Extended-Release tablets manage hypertension (high blood pressure) when other treatments are insufficient. This medication lowers blood pressure, reducing the risk of future strokes and heart attacks. Early use significantly improves heart attack survival rates. Take Cardiolol XT once daily, preferably in the morning, with or without food, to minimize nighttime urination. Continue treatment as directed by your physician; discontinuing it prematurely, even if feeling well, can worsen your condition as hypertension often presents without symptoms. Lifestyle changes including regular exercise, weight management, and a healthy diet further enhance blood pressure control. Follow your doctor’s instructions carefully. Common side effects may include nausea, constipation, diarrhea, and tiredness. Report any persistent, worsening, or bothersome side effects. Increased fluid intake may alleviate muscle weakness, dry mouth, and thirst. Low blood pressure may cause dizziness or headaches; rise slowly from a seated position and avoid driving if affected. Inform your doctor about any pre-existing liver or kidney conditions, pregnancy, breastfeeding, or other medications, particularly those for heart conditions or hypertension, before starting Cardiolol XT. Regular monitoring of blood pressure, kidney function, blood sugar, and electrolyte levels (potassium and magnesium) is crucial to ensure the medicine's effectiveness.

Uses of Vrimolol H 50/12.5 Tablet ER

Elevated arterial blood pressure

Major Benefits of Vrimolol H 50/12.5 Tablet ER:

Consume Vrimolol H 50/12.5 Tablet ER precisely as prescribed by your physician, adhering to both the dosage and treatment length. The tablet should be swallowed whole; avoid chewing, crushing, or fracturing it. While it can be ingested with or without food, consistent daily timing is recommended.

Common Side effects of Vrimolol H 50/12.5 Tablet ER:

  • Fatigue
  • Nasopharyngitis (inflammation of the throat and nasal passages)

How to use Vrimolol H 50/12.5 Tablet ER:

Administer Vrimolol H 50/12.5 Tablet ER precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Consumption with or without food is acceptable; however, consistent daily timing is recommended.

How Vrimolol H 50/12.5 Tablet ER works:

Vrimolol H 50/12.5 Extended-Release tablets combine metoprolol succinate, a beta-blocker, and hydrochlorothiazide, a diuretic, to control hypertension. Metoprolol succinate acts on the heart, slowing the heartbeat and enhancing its pumping efficiency. Hydrochlorothiazide reduces blood pressure by promoting fluid and electrolyte excretion, concurrently relaxing blood vessels and boosting circulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vrimolol H 50/12.5 Tablet ER with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Vrimolol H 50/12.5 mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Vrimolol H 50/12.5 tablets are likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with the medication.

DrivingDrivingUNSAFE

Extended-release Vrimolol H 50/12.5 mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when using Vrimolol H 50/12.5 Tablet ER, potentially requiring dosage modification. Medical advice is essential. Vrimolol H 50/12.5 Tablet ER is contraindicated for individuals with severe renal dysfunction.

LiverLiverCAUTION

Patients with hepatic impairment should use Vrimolol H 50/12.5 Extended-Release tablets cautiously. Dosage modification may be necessary; physician consultation is advised.

What if you forget to take Vrimolol H 50/12.5 Tablet ER :

Should you forget to take a Vrimolol H 50/12.5 Tablet ER, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vrimolol H 50/12.5 Tablet ER

LabelValue
Developing Habits No.
Type of Therapy Heart
Vrimolol H 50/12.5 Tablet...
103
MRP 119
13% off